Active ingredient

Registrations named Para

Para is an active ingredient, not a brand name. 10 registrations in the DRAP register carry it in the product name, and the price index attributes them to 3 manufacturers — these are generic products, not one company's range.

Registrations
10
Manufacturers
3
Dosage forms
Tablet · Suspension · Infusion
Approved price range
Rs 66.01 – Rs 1,955.12

Registrations

Registered nameReg. No.StrengthFormManufacturerPrice from
Para + CF Tablet053272—TabletMediate Pharmaceutical Pvt LtdRs 190.65
Para 120mg Suspension024946120mgSuspension——
Para 1g/100ml Infusion0996111g/100mlInfusion——
Para 4 Kids Suspension002435-EX—Suspension——
Para 4 Kids Suspension067149—SuspensionZafa Pharmaceutical Laboratories (Pvt) Ltd.Rs 66.01
Para 6+ Suspension 250mg/5ml070404250mg/5mlSuspensionZafa Pharmaceutical Laboratories (Pvt) Ltd.Rs 94.97
Para 6+Suspension 250mg/5ml067572250mg/5mlSuspension——
Para Tablet071443—Tablet——
Para-250 Suspension022008—Suspension——
Para-Plus Tablet013592—TabletUNEXOLABS (PVT) LTD.Rs 438.32

Why this is not described as a brand

The DRAP register has no separate brand column, so an ingredient name and a trade name look identical in the data. This group is an ingredient: the products below are made by different companies under their own trade names, and no single company owns the word.

How these are grouped

These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.

Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.